Precision Optics Corporation Celebrates FDA Clearance
Recently, Precision Optics Corporation, Inc. (NASDAQ: POCI), based in Massachusetts, made headlines in the medical device industry by announcing a significant achievement for its customer—a surgical robotics company specializing in innovative solutions for urology. The announcement highlighted that this customer has received FDA 510(k) clearance for their cutting-edge, AI-powered platform designed to treat Benign Prostate Hyperplasia.
Unveiling a New Era in Surgical Robotics
This news is particularly exciting not just for the surgical robotics company, but also for Precision Optics, which designed and manufactures the essential single-use endoscope imaging assembly integral to this state-of-the-art system. Dr. Joe Forkey, CEO of Precision Optics, expressed his enthusiasm regarding the FDA clearance, stating, “We are thrilled with our customer’s progress and the potential this technology holds for improving patient care.”
A Strong Partnership in Innovation
Thanks to rigorous collaboration, the technical and production teams from Precision Optics have successfully created this complex imaging component. Their partnership has led to an accelerated commercial timeline, enabling early clinical use of the new robotic surgery system. Precision Optics leveraged its specialized micro-optics and digital imaging technologies to ensure the assembly met stringent technical requirements while addressing critical reimbursement constraints associated with single-use medical devices.
Market Potential and Production Growth
The market for treating Benign Prostate Hyperplasia is already substantial and appears poised for even more growth. Both Precision Optics and its customer remain confident that the success of the new AI-driven robotic platform will lead to multiplied business opportunities over time. This optimism is built on the successful launches of prior systems and the expanding need for advanced surgical solutions.
Production Orders and Revenue Expectations
Aligning with the newfound momentum, Precision Optics commenced production deliveries for the endoscope imaging assembly as part of a significant $9 million order announced earlier in the year. The company projects around $3.6 million in product deliveries for the fiscal year ending June 2025, reinforcing its commitment to supporting the deployment of innovative medical systems in the market.
About Precision Optics Corporation
Precision Optics Corporation has been operational since 1982 and dedicates itself to pairing advanced optical design with manufacturing. It primarily serves the healthcare and defense sectors with its proprietary technologies. Their capability spans from concept development to mass production, reflecting its comprehensive expertise in the field.
With in-house design, prototyping, and regulatory capabilities, along with an emphasis on manufacturing excellence, Precision Optics continues to develop next-generation products for sectors where precision is critical. By addressing the growing demand for minimally invasive surgery technologies like single-use endoscopes and fostering innovation in 3D imaging for surgical applications, the company maintains its position as a trusted partner among top-tier medical device manufacturers.
Company Information and Contact
Precision Optics is strategically positioned to serve the needs of the surgical community globally, ensuring they have access to the most reliable optical products and systems in the market. They also provide specialized support to defense and aerospace applications, meeting rigorous standards for quality and performance.
If you need to reach out to Precision Optics Corporation, you can find the following contact details:
Address:
22 East Broadway, Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800
Frequently Asked Questions
What does FDA 510(k) clearance mean for Precision Optics’ customer?
FDA 510(k) clearance indicates that the device is considered safe and effective for its intended use, allowing the customer to market their new robotic system.
How does the single-use endoscope assembly contribute to surgical procedures?
The assembly provides essential imaging capabilities that support minimally invasive surgical techniques, enhancing patient outcomes.
What is the projected market growth for Benign Prostate Hyperplasia treatments?
The market is expected to experience significant growth due to the demand for advanced treatment solutions like AI-driven robotic platforms.
How much revenue does Precision Optics anticipate from the recent order?
Precision Optics estimates approximately $3.6 million in product deliveries from the recent order during the fiscal year.
How does Precision Optics maintain quality in its products?
Precision Optics employs strict manufacturing standards and leverages advanced technologies to ensure high-quality outcomes for its medical devices.
